Autonomous TGFβ signaling induces phenotypic variation in human acute myeloid leukemia. (15th February 2021)
- Record Type:
- Journal Article
- Title:
- Autonomous TGFβ signaling induces phenotypic variation in human acute myeloid leukemia. (15th February 2021)
- Main Title:
- Autonomous TGFβ signaling induces phenotypic variation in human acute myeloid leukemia
- Authors:
- Shingai, Yasuhiro
Yokota, Takafumi
Okuzaki, Daisuke
Sudo, Takao
Ishibashi, Tomohiko
Doi, Yukiko
Ueda, Tomoaki
Ozawa, Takayuki
Nakai, Ritsuko
Tanimura, Akira
Ichii, Michiko
Shibayama, Hirohiko
Kanakura, Yuzuru
Hosen, Naoki - Abstract:
- Abstract: Heterogeneity of leukemia stem cells (LSCs) is involved in their collective chemoresistance. To eradicate LSCs, it is necessary to understand the mechanisms underlying their heterogeneity. Here, we aimed to identify signals responsible for heterogeneity and variation of LSCs in human acute myeloid leukemia (AML). Monitoring expression levels of endothelial cell-selective adhesion molecule (ESAM), a hematopoietic stem cell-related marker, was useful to detect the plasticity of AML cells. While healthy human hematopoietic stem/progenitor cells robustly expressed ESAM, AML cells exhibited heterogeneous ESAM expression. Interestingly, ESAM − and ESAM + leukemia cells obtained from AML patients were mutually interconvertible in culture. KG1a and CMK, human AML clones, also represented the heterogeneity in terms of ESAM expression. Single cell culture with ESAM − or ESAM + AML clones recapitulated the phenotypic interconversion. The phenotypic alteration was regulated at the gene expression level, and RNA sequencing revealed activation of TGFβ signaling in these cells. AML cells secreted TGFβ1, which autonomously activated TGFβ pathway and induced their phenotypic variation. Surprisingly, TGFβ signaling blockade inhibited not only the variation but also the proliferation of AML cells. Therefore, autonomous activation of TGFβ signaling underlies the LSC heterogeneity, which may be a promising therapeutic target for AML. Abstract : Leukemic stem cells (LSCs) in human acuteAbstract: Heterogeneity of leukemia stem cells (LSCs) is involved in their collective chemoresistance. To eradicate LSCs, it is necessary to understand the mechanisms underlying their heterogeneity. Here, we aimed to identify signals responsible for heterogeneity and variation of LSCs in human acute myeloid leukemia (AML). Monitoring expression levels of endothelial cell-selective adhesion molecule (ESAM), a hematopoietic stem cell-related marker, was useful to detect the plasticity of AML cells. While healthy human hematopoietic stem/progenitor cells robustly expressed ESAM, AML cells exhibited heterogeneous ESAM expression. Interestingly, ESAM − and ESAM + leukemia cells obtained from AML patients were mutually interconvertible in culture. KG1a and CMK, human AML clones, also represented the heterogeneity in terms of ESAM expression. Single cell culture with ESAM − or ESAM + AML clones recapitulated the phenotypic interconversion. The phenotypic alteration was regulated at the gene expression level, and RNA sequencing revealed activation of TGFβ signaling in these cells. AML cells secreted TGFβ1, which autonomously activated TGFβ pathway and induced their phenotypic variation. Surprisingly, TGFβ signaling blockade inhibited not only the variation but also the proliferation of AML cells. Therefore, autonomous activation of TGFβ signaling underlies the LSC heterogeneity, which may be a promising therapeutic target for AML. Abstract : Leukemic stem cells (LSCs) in human acute myeloid leukemia (AML) represent phenotypic variability, which is delineated by endothelial cell-selective adhesion molecule (ESAM) expression. The variable ESAM levels reflect fluctuating transcriptome in LSCs that is at least partly regulated by autocrine/paracrine cytokine signals. While autonomous TGFβ1 signaling promotes the phenotypic variability of LSCs, blocking the signaling inhibits not only their variability but also their growth by inducing apoptosis. … (more)
- Is Part Of:
- Stem cells. Volume 39:Number 6(2021)
- Journal:
- Stem cells
- Issue:
- Volume 39:Number 6(2021)
- Issue Display:
- Volume 39, Issue 6 (2021)
- Year:
- 2021
- Volume:
- 39
- Issue:
- 6
- Issue Sort Value:
- 2021-0039-0006-0000
- Page Start:
- 723
- Page End:
- 736
- Publication Date:
- 2021-02-15
- Subjects:
- acute myeloid leukemia -- autonomous signaling -- chemoresistance -- endothelial cell-selective adhesion molecule -- heterogeneity -- leukemia stem cells -- phenotypic variation -- TGFβ
Cloning -- Periodicals
Clone cells -- Periodicals
Stem cells -- Periodicals
Cell Differentiation -- Periodicals
Cell Division -- Periodicals
Clone Cells -- Periodicals
Hematopoietic Stem Cells -- Periodicals
Stem Cells -- Periodicals
571.84 - Journal URLs:
- https://academic.oup.com/stmcls ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/stem.3348 ↗
- Languages:
- English
- ISSNs:
- 1066-5099
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8464.133510
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20748.xml